RecruitingNAINTERVENTIONAL

Salutare One Referral Software Impact on Multi-Disciplinary Team (MDT) Meetings Effectiveness and Safety

This study is looking at new software, 'Salutare One Referral', designed to help hospital teams called Multi-Disciplinary Teams (MDTs) plan care for cancer patients, especially those with solid tumours and sarcoma. MDT meetings are vital for deciding the best treatment, but they can be slow and sometimes lack all the necessary patient information, which can delay care. The software aims to make these meetings much more efficient and effective. We want to see if it helps healthcare staff prepare information more easily and leads to better discussions, ultimately improving patient care across the NHS. If successful, it could mean faster and better-coordinated treatment decisions for many patients.

At a glance

Status

Recruiting

Phase

Sponsor

Salutare Group Ltd.

Enrolment target

Start

31 Jul 2025

Estimated completion

19 Jul 2026

Cancer (Solid Tumors)Sarcoma

What is this study about?

When someone has cancer, a team of different doctors and nurses, called a Multi-Disciplinary Team (MDT), comes together to discuss their case and decide on the best treatment plan. These meetings are really important, but sometimes they can be complex. For example, information might not always be complete, or cases might need to be discussed multiple times, which can slow things down for patients and their care.

This study is testing a new computer programme called 'Salutare One Referral'. This software is designed to make these important MDT meetings work better. It aims to help the healthcare staff prepare patient information more easily and ensure that all the necessary details are available for a good discussion. The main goal is to see if using this software means that the teams can make quicker and more informed decisions about patient care.

Ultimately, if 'Salutare One Referral' works well, it could help improve how these crucial meetings run across the NHS. This could lead to a smoother and faster journey for patients needing cancer treatment, ensuring they get the right care at the right time. We are carefully checking if the software is safe to use and if it genuinely makes the MDT meetings more effective.

Key takeaways

Tests new software ('Salutare One Referral') for hospital team meetings.
Aims to make cancer care planning more efficient and effective.
Could lead to faster and better-coordinated treatment for patients.
Involves healthcare staff using the software in their regular work.
Patient privacy is protected by using de-identified data.
Focuses on improving Multi-Disciplinary Team (MDT) meetings in the NHS.

Who may be eligible?

This study is for healthcare professionals who are involved in Multi-Disciplinary Team (MDT) meetings for cancer patients. This includes the main members of the MDT panel, the people who coordinate these meetings, and the staff who send patient information to be discussed at the MDT.

You would be able to take part if you are one of these healthcare professionals and you are willing to participate in the study. You would not be able to join if you are unwilling or unable to contribute to the research.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

Are you a healthcare professional involved in cancer MDT meetings?
Are you a panel member, coordinator, or staff submitting referrals to an MDT?
Are you willing and able to take part in a study testing new computer software?
Do you work within an NHS MDT setting that treats solid tumours or sarcoma?

Answer every question to see your result.

What does participation involve?

This study will watch how MDT meetings work both with and without the new software. It's set up as a 'before and after' study. Healthcare staff will use the Salutare One Referral software during their normal MDT meetings for a period, and then participate in a period without it, followed by another period with the software. There will also be a period where the software is not used to see the difference.

If you are a member of an MDT taking part, you would use the Salutare One Referral software as part of your regular work during the study periods. You would also be asked to fill out questionnaires about your experiences using the software and how it affected the meetings. Patient data will be looked at in a way that protects privacy (it will be 'pseudonymised', meaning it won't directly identify individuals) to see if the MDT reviews are better.

Potential risks and benefits

This study primarily involves healthcare professionals using new software, so the direct medical risks to patients are expected to be very low. The main potential benefit is that if the software works well, it could lead to more efficient and effective MDT meetings, meaning clearer, faster, and better-coordinated treatment plans for patients in the future. As a participant in the MDT team, you would be helping to improve NHS processes. You would, of course, be free to withdraw your consent to participate in the study at any time without affecting your normal work.

Locations (1)

Some site locations are approximate. We're improving this — please verify with the trial team before travelling.

Royal National Orthopaedic Hospital
Verified postcode
London, United Kingdom· Recruiting

Common questions

What is an MDT meeting?

An MDT, or Multi-Disciplinary Team, is a group of different healthcare experts, like doctors and nurses, who meet to discuss a patient's case and plan their treatment together.

What is 'Salutare One Referral'?

'Salutare One Referral' is new software designed to make MDT meetings more organised and efficient, helping teams share information and make decisions more easily.

What kind of patients will this study help?

This study aims to improve the care planning process for cancer patients, especially those with solid tumours and sarcoma, by making MDT meetings more effective.

Will my personal patient information be safe?

Yes, any patient data used in this study will be 'pseudonymised', meaning it will be de-identified so that individual patients cannot be recognised or identified.

Who is involved in this study?

This study involves healthcare professionals who are part of MDT meetings, including panel members, coordinators, and staff who send patient information for discussion.

How to find out more

Liba Stones, MA, MBA

liba@dicro.co.uk +447443940319 Official trial record

Always speak to your GP or specialist before deciding to take part in a study.